新型儿茶酚胺释放抑制肽癌抑素（嗜铬粒蛋白A344 - 364）。特性与功能。 - Suppr

The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.

作者信息

Mahata S K, Mahata M, Livsey Taylor C V, Taupenot L, Parmer R J, O'Connor D T

机构信息

Department of Medicine and Center for Molecular Genetics, University of California, and Veterans Affairs, San Diego Healthcare System, San Diego, California 92161-9111, USA.

出版信息

Adv Exp Med Biol. 2000;482:263-77. doi: 10.1007/0-306-46837-9_21.

DOI:10.1007/0-306-46837-9_21

PMID:11192587

Abstract

摘要

相似文献

The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.

Adv Exp Med Biol. 2000;482:263-77. doi: 10.1007/0-306-46837-9_21.

Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.

Mol Endocrinol. 2000 Oct;14(10):1525-35. doi: 10.1210/mend.14.10.0531.

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

J Clin Invest. 1997 Sep 15;100(6):1623-33. doi: 10.1172/JCI119686.

The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.

Mol Pharmacol. 2004 Nov;66(5):1180-91. doi: 10.1124/mol.104.002139. Epub 2004 Aug 23.

The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.

J Hypertens. 2006 May;24(5):895-904. doi: 10.1097/01.hjh.0000222760.99852.e0.

Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.

Regul Pept. 2004 Apr 15;118(1-2):75-87. doi: 10.1016/j.regpep.2003.10.035.

Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.

Regul Pept. 2000 Nov 24;95(1-3):9-17. doi: 10.1016/s0167-0115(00)00135-x.

Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.

J Biol Chem. 1999 Jan 29;274(5):2920-8. doi: 10.1074/jbc.274.5.2920.

A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.

Adv Pharmacol. 1998;42:260-4. doi: 10.1016/s1054-3589(08)60743-7.

Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.

J Biol Chem. 2003 Aug 22;278(34):32058-67. doi: 10.1074/jbc.M305545200. Epub 2003 Jun 10.

引用本文的文献

D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections.

Sci Rep. 2018 Jun 18;8(1):9235. doi: 10.1038/s41598-018-27417-x.

Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertension.

J Cardiovasc Transl Res. 2014 Jul;7(5):483-493. doi: 10.1007/s12265-014-9563-7. Epub 2014 May 13.

PACAP-cytokine interactions govern adrenal neuropeptide biosynthesis after systemic administration of LPS.

Neuropharmacology. 2010 Jan;58(1):208-14. doi: 10.1016/j.neuropharm.2009.07.034. Epub 2009 Jul 31.

An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension.

Hum Mol Genet. 2007 Jul 15;16(14):1752-64. doi: 10.1093/hmg/ddm123. Epub 2007 Jun 21.

Tetrapeptides on N- and C-terminal regions of mastoparan inhibit catecholamine release from chromaffin cells by blocking nicotinic acetylcholine receptor.

Cell Mol Neurobiol. 2004 Feb;24(1):37-50. doi: 10.1023/b:cemn.0000012723.52742.84.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.

作者信息

Mahata S K, Mahata M, Livsey Taylor C V, Taupenot L, Parmer R J, O'Connor D T

机构信息

Department of Medicine and Center for Molecular Genetics, University of California, and Veterans Affairs, San Diego Healthcare System, San Diego, California 92161-9111, USA.

出版信息

Adv Exp Med Biol. 2000;482:263-77. doi: 10.1007/0-306-46837-9_21.

DOI:10.1007/0-306-46837-9_21

PMID:11192587

Abstract

摘要

The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.

作者信息

机构信息

出版信息

相似文献

引用本文的文献